[Federal Register Volume 89, Number 20 (Tuesday, January 30, 2024)]
[Notices]
[Page 5918]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2024-01812]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

National Institutes of Health


National Institute of Arthritis and Musculoskeletal and Skin 
Diseases; Notice of Closed Meetings

    Pursuant to section 1009 of the Federal Advisory Committee Act, as 
amended, notice is hereby given of the following meetings.
    The meetings will be closed to the public in accordance with the 
provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5 
U.S.C., as amended. The grant applications and the discussions could 
disclose confidential trade secrets or commercial property such as 
patentable material, and personal information concerning individuals 
associated with the grant applications, the disclosure of which would 
constitute a clearly unwarranted invasion of personal privacy.

    Name of Committee: National Institute of Arthritis and 
Musculoskeletal and Skin Diseases Special Emphasis Panel; AMSC 
Member Conflict Review.
    Date: February 20, 2024.
    Time: 11:00 a.m. to 1:00 p.m.
    Agenda: To review and evaluate grant applications.
    Place: National Institute of Arthritis and Musculoskeletal and 
Skin Diseases, National Institutes of Health, One Democracy Plaza, 
6701 Democracy Boulevard, Bethesda, MD 20892 (Virtual Meeting).
    Contact Person: Kan Ma, Ph.D., Scientific Review Officer, 
Scientific Review Branch, National Institute of Arthritis, 
Musculoskeletal and Skin Diseases, NIH, 6701 Democracy Boulevard, 
Suite 814, Bethesda, MD 20892, 301-451-4838, [email protected].

    Name of Committee: National Institute of Arthritis and 
Musculoskeletal and Skin Diseases Special Emphasis Panel; NIAMS AMS 
Member Conflict Review Meeting.
    Date: March 12, 2024.
    Time: 11:00 a.m. to 3:00 p.m.
    Agenda: To review and evaluate grant applications.
    Place: National Institute of Arthritis and Musculoskeletal and 
Skin Diseases, National Institutes of Health, One Democracy Plaza, 
6701 Democracy Boulevard, Bethesda, MD 20892 (Virtual Meeting).
    Contact Person: Sushmita Purkayastha, Ph.D., Scientific Review 
Officer, Scientific Review Branch National Institute of Arthritis, 
Musculoskeletal and Skin Diseases, NIH, One Democracy Plaza, 6701 
Democracy Boulevard, Room 814, Bethesda, MD 20892, 
[email protected].

    Name of Committee: National Institute of Arthritis and 
Musculoskeletal and Skin Diseases Special Emphasis Panel; P30 Core 
Centers for Clinical Research Meeting.
    Date: March 14-15, 2024.
    Time: 10:00 a.m. to 5:00 p.m.
    Agenda: To review and evaluate grant applications.
    Place: National Institute of Arthritis and Musculoskeletal and 
Skin Diseases, National Institutes of Health, One Democracy Plaza, 
6701 Democracy Boulevard, Bethesda, MD 20892 (Virtual Meeting).
    Contact Person: Kan Ma, Ph.D., Scientific Review Officer 
Scientific Review Branch National Institute of Arthritis, 
Musculoskeletal and Skin Diseases, NIH, 6701 Democracy Boulevard, 
Suite 814, Bethesda, MD 20892, 301-451-4838, [email protected].

    Name of Committee: National Institute of Arthritis and 
Musculoskeletal and Skin Diseases Special Emphasis Panel; NIAMS 
Ancillary Studies Review Meeting.
    Date: March 19, 2024.
    Time: 10:30 a.m. to 5:30 p.m.
    Agenda: To review and evaluate grant applications.
    Place: National Institute of Arthritis and Musculoskeletal and 
Skin Diseases, National Institutes of Health, One Democracy Plaza, 
6701 Democracy Boulevard, Bethesda, MD 20892 (Virtual Meeting).
    Contact Person: Archana Jha, Ph.D., Scientific Review Officer, 
Scientific Review Branch, National Institute of Arthritis, 
Musculoskeletal and Skin Diseases, NIH, 6701 Democracy Boulevard, 
Suite 800, Bethesda, MD 20892 301-480-2159 [email protected].

(Catalogue of Federal Domestic Assistance Program Nos. 93.846, 
Arthritis, Musculoskeletal and Skin Diseases Research, National 
Institutes of Health, HHS)

    Dated: January 25, 2024.
Miguelina Perez,
Program Analyst, Office of Federal Advisory Committee Policy.
[FR Doc. 2024-01812 Filed 1-29-24; 8:45 am]
BILLING CODE 4140-01-P